What is UniteLabs?
UniteLabs is at the forefront of revolutionizing scientific discovery through its foundational operating system for AI-driven lab automation. The company's platform is engineered to accelerate research by unifying data and automation infrastructure, offering seamless integration and intelligent control. It caters to ambitious biotech firms, large pharmaceutical companies, system integrators, and hardware manufacturers. UniteLabs provides bidirectional connectors for a wide array of laboratory equipment, a scalable cloud platform with an open API, and a robust workflow engine complemented by an integrated compute environment. This comprehensive suite enables the development of sophisticated, modular workflows and facilitates rapid automation development via its Lab-as-Code environment, which includes a dynamic Python SDK and specialized application libraries.
How much funding has UniteLabs raised?
UniteLabs has raised a total of $3M across 1 funding round:
Other Financing Round
$3M
Other Financing Round (2025): $3M with participation from NAP, Acurio Ventures, and LANA Ventures
Key Investors in UniteLabs
LANA Ventures
LANA Ventures LLC is a Houston-based entity operating in the Information & Document Management sector, likely focusing on technology investments that enhance data infrastructure and operational efficiency.
NAP
NAP is an undisclosed investor participating in this funding round, indicating a strategic interest in the AI and lab automation space.
Acurio Ventures
Acurio Ventures is an investor that has contributed to this financing round, signaling a belief in UniteLabs' potential within the life science automation market.
What's next for UniteLabs?
The recent major strategic investment positions UniteLabs for accelerated growth and expanded market penetration. This capital infusion is expected to fuel further development of its AI-driven automation platform, enhance its integration capabilities with diverse lab equipment, and broaden its reach within the life science and biotech industries. The company's focus on a unified data and automation infrastructure, coupled with its Lab-as-Code environment, suggests a strategic push towards making advanced automation more accessible and efficient for scientific research, potentially leading to faster drug discovery and development cycles.
See full UniteLabs company page
